Description
Most hormone support formulas give practitioners one estrogen metabolism tool. This one provides three that work through different mechanisms. DIM shifts estrogen metabolism toward the 2-hydroxy pathway and away from the 16-alpha-hydroxy metabolites associated with estrogen-dominant symptoms. Calcium D-glucarate at 400mg inhibits beta-glucuronidase — the gut enzyme that deconjugates cleared estrogens and allows them to be reabsorbed into circulation, addressing the GI clearance piece that DIM alone doesn’t touch. The broccoli seed extract and mustard seed myrosinase pairing is where the formulation gets specific: most broccoli-extract products contain glucoraphanin, the sulforaphane precursor, but active sulforaphane requires the myrosinase enzyme — which is largely destroyed in standard processing. Adding mustard seed myrosinase separately ensures the conversion actually happens. DIM for pathway shifting, calcium D-glucarate for GI clearance, sulforaphane for phase II enzyme induction — these mechanisms are complementary, not redundant.
Vitex at 200mg supports LH/FSH ratio and the dopaminergic activity that modulates prolactin, making it relevant for cycle regularity and luteal phase support. Resveratrol adds antioxidant and cellular protection. Selenium is in the formula because thyroid-estrogen disruption co-presents often enough in this patient population that leaving it out felt like an oversight. The B vitamins — 5-MTHF, methylcobalamin, and B6 — are in active forms because methylation is upstream of estrogen clearance and a significant share of these patients have methylation vulnerabilities. I reach for this most with patients presenting with estrogen-dominant symptoms — heavy or irregular cycles, breast tenderness, luteal phase mood changes — and with perimenopausal patients navigating the fluctuating estrogen of the transition. It’s a four-capsule serving, which I factor into compliance conversations, but the mechanism coverage is what these presentations require.
